BioSpace News Archive

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, today announced financial results for the fourth quarter and full year ended December 31, 2018.

Underwriters Exercise Over-Allotment Option in Full

Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States, announced that NFL Hall of Famer and former Rams running back Eric Dickerson will be giving a keynote speech at the Believe National Convention in San Diego on April 14, 2019.

Additions support increased demand and complexity in oncology drug development and commercialization

Grants further Synthego’s mission of providing the next generation of Genome Engineers access to CRISPR tools to enable novel research

Included in the recent patent grants is the Company’s first patent in China titled “Articulated Tool Positioner and System Employing Same,” for which the Company announced a notice of allowance in December 2018

SRC Health now offers the most extensive range of maternity compression items.

Dominic Paniccia has been appointed its new CEO, effective March 31, 2019.

The loupes, made in the United States, are the first on the market to feature colored oculars and are available in green, blue, pink, silver, and black.

Survey of 1,000 regional consumers shows demand for real-time use of all health records